The FDA approved the gene therapy Zolgensma to treat children with a severe form of spinal muscular atrophy. The drug costs $2.125 million for a one-time treatment, CBS News reported.
↧
Channel:
Inclusive Of Talent
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: Inclusive Of Talent
- Channel Number: 74535235
- Language: English
- Registered On: June 15, 2019, 8:06 am
- Number of Articles: 1846
- Latest Snapshot: April 3, 2020, 5:43 am
- RSS URL: http://feeds.feedburner.com/inclusiveoftalent
- Publisher: http://news-round.com/feeds/8155581908-inclusive-of-talent
- Description: Small business should be inclusive
- Catalog: //inclusiveoftalent.rssing.com/catalog.php?indx=74535235
© 2025 //www.rssing.com